DR. WESLEY C. FOWLER III, MD

Plain English
This study evaluated how surgical trainees in the Northern Deanery are learning robotic surgery, which is becoming more common in operations across the UK. Out of 60 trainees surveyed, 97% supported formal training in robotic surgery, while 80% felt that access to training varied unfairly between hospitals. Most trainees reported feeling ready to assist in robotic surgeries, but only a small number had actually operated the robotic system themselves, highlighting a need for improved training access. Who this helps: This helps surgical trainees and ultimately benefits patients needing robotic-assisted surgeries.

Plain English
This study looked at the safety of major surgeries for patients with urinary cancers (like prostate, bladder, and kidney cancers) during the COVID-19 pandemic, examining 598 operations done in the UK. Only four patients (0.7%) caught COVID-19 after their surgeries, and there were no deaths related to COVID-19 within 30 days. This shows that these surgeries can be safely performed even during a pandemic, and that training new surgeons should continue under proper safety measures. Who this helps: This helps patients needing cancer surgery and the doctors who perform these operations.

Plain English
This study looked at a new test called the Xpert HIV-1 Viral Load Assay to see how well it measures the amount of HIV in blood and whether it can help diagnose HIV infections. The researchers found that the Xpert test correctly identified 97.9% of people with known HIV and showed a strong agreement with an existing test (98.5% accuracy in late infections). This matters because, if approved, it could allow more labs to monitor HIV infections easily, especially those that can't use more complicated testing methods. Who this helps: This helps patients by providing quicker and easier access to HIV testing and monitoring.

Plain English
This study looked at how well an activated carbon disposal system can safely deactivate unused sedative medications to prevent issues like accidental overdoses or contamination. The researchers found that over 94% of the medications were deactivated within 8 hours, and this increased to over 99% after 28 days, with only 0.25% of drugs leaking into the surrounding solutions. This is important because it provides a reliable way for people to dispose of expired medications without harming the environment or risking public safety. Who this helps: This helps patients and the community by reducing the risks associated with unused medications.

Plain English
This study looked at a new disposal method for unused opioid medications to prevent abuse and environmental harm. Researchers found that this system, using a pouch filled with activated carbon, effectively neutralized more than 99.99% of the opioids tested within 28 days. This is important because it provides a safe and convenient way to dispose of prescription opioids, reducing the risk of misuse and pollution. Who this helps: This benefits patients, healthcare providers, and communities concerned about opioid abuse and environmental safety.

Plain English
This study focused on new rules in Louisiana that limit how much screen time children can have in early care and education centers while promoting more physical activity. Researchers worked with community members and childcare directors to assess how well these rules were being implemented and to create resources to help directors manage the changes. They found that working together with stakeholders and involving directors actively led to better strategies for keeping kids active and engaged. Who this helps: This benefits early childhood education centers and the children they serve.

Plain English
This research focused on understanding how specific Sox genes are expressed during the early development of different panarthropods, which include groups like insects, millipedes, and velvet worms. The study identified 24 Sox genes across three different species: 9 in the flour beetle, 8 in the pill millipede, and 7 in the velvet worm, finding that certain genes are critical for developing the nervous system and other body segments. This research is important because it helps us understand the roles these genes play in animal development, which can provide insights into broader biological processes. Who this helps: This benefits researchers studying genetics, developmental biology, and evolutionary relationships among different animal groups.

Plain English
This study looked at how well a new drug disposal pouch works to safely deactivate unused medications like methylphenidate hydrochloride and loxapine succinate. The researchers developed a reliable testing method and found that the pouch effectively neutralized these drugs, proving to be both efficient and safe for preventing abuse and environmental harm. The testing showed a strong tracking ability for both medications, ensuring they can be effectively monitored as they are disposed of. Who this helps: This helps patients, their families, and communities by providing a safe way to dispose of unused medications.

Plain English
This study focused on finding safe ways to dispose of unused, leftover, or expired medications. Researchers tested different chemicals and materials to see how effectively they could break down four specific drugs, including metformin and amoxicillin. They found that activated carbon worked best, successfully deactivating most medications and keeping them from causing harm, making this method both safe and environmentally friendly. Who this helps: This benefits patients and healthcare providers by reducing the risk of improperly discarded medications harming the environment or public health.

Plain English
This study looked at a new system using activated carbon to safely dispose of psychoactive medications, which are often misused and cause safety and environmental issues. The researchers found that this system effectively deactivated over 99% of diazepam, lorazepam, and buprenorphine after 28 days, with significant amounts (up to 97%) being locked away in just 8 hours and less than 1% leaking back out. This method provides a reliable way to dispose of these medications, ensuring that they don't pose a risk to people or the environment. Who this helps: Patients, doctors, and communities concerned about medication safety.

Plain English
This study looked at how Australian plants, specifically those that regrow after fire, adapt to declining rainfall. Researchers found that seedlings from plants that grew in very dry years were better at using water, had denser leaves, and generally survived better in drought conditions compared to those from wetter years. These findings show that some plants can quickly adapt to changes in climate, but this ability varies between species based on their environmental history. Who this helps: This research benefits ecologists and conservationists working to protect plant species in changing climates.

Plain English
This paper looks at endometrial cancer, which is the fourth most common type of cancer in women in the U.S. The study highlights that while early-stage cases can often be treated successfully with surgery and radiation, advanced stages of the disease have a much poorer outlook. Current treatments for later-stage cancer can be very tough on patients, who are often older and dealing with other health issues. Who this helps: This research benefits patients with endometrial cancer and their doctors by providing insights into better management strategies.

Plain English
This study looked at how patients with early-stage vulvar cancer fare after surgery that removes lymph nodes and the vulva. Out of 65 patients, only 4.6% had cancer come back in the lymph node area, and 16.9% had recurrences on the vulva. Overall, the five-year survival rate was 97%, indicating that this surgical approach is effective, leading to a low chance of cancer returning, which is important for patients' long-term health. Who this helps: This helps patients with early-stage vulvar cancer and their doctors in making treatment decisions.

Plain English
This study looked at a rare type of cancer called vaginal leiomyosarcoma, which is a malignant tumor found in less than 2% of all vaginal cancers. The researchers reported a case of this cancer developing in a woman who had previously undergone a specific medical procedure (TVT) that used a type of tissue graft. It’s important to know about this connection because it highlights a new possible complication linked to this procedure, even though the particular graft studied is no longer used. Who this helps: This information helps doctors and patients understand the potential risks of certain surgical procedures.

Plain English
This research focused on 94 patients with early-stage cervical cancer to understand how deep the tumor had grown and whether it had spread to lymph nodes. The study found that 7.4% of the patients had cancer spread to their lymph nodes, and those with lymph vascular space invasion (LVSI) had a higher risk of cancer recurrence and slightly lower survival rates. Specifically, the 5-year survival rate was 89% for patients with LVSI compared to 98% for those without it, and overall, 95% of these patients survived for five years post-treatment. Who this helps: This study helps patients with cervical cancer and their doctors in making informed treatment decisions.

Plain English
This study looked at early genetic changes in lung cancer by examining 97 samples of lung tissue and precancerous lesions. Researchers found that certain genetic changes, like alterations on chromosome 3 and in the p53 gene, are present in these early lesions, which is a sign that they could develop into lung cancer. This is important because identifying these changes early could help in diagnosing lung cancer sooner and potentially improving treatment outcomes. Who this helps: Patients at risk for lung cancer and their doctors.

Plain English
The study looked at how language and other skills can be improved in children who received extra support during their early years. It found that out of 44 children who were part of a language enrichment program, 62-93% were doing well academically, participating in gifted programs, and excelling in reading and writing; many even read before starting school. This matters because it shows that early language support can significantly boost a child's skills and confidence, leading to better outcomes later in life. Who this helps: This benefits children and their families, especially those from diverse backgrounds.

Plain English
This study looked at a combination of radiation therapy and chemotherapy to treat patients with advanced lung cancer that could not initially be operated on. The researchers treated 41 patients and found that 90% had a positive response to the treatment, with 38% surviving for at least two years. While this aggressive treatment showed promising survival rates, it also caused significant side effects, particularly severe throat inflammation in 80% of patients. Who this helps: This research benefits patients with advanced non-small cell lung cancer by providing insights into effective treatment options.

Plain English
This study looked at how a treatment called intraperitoneal chromic phosphate (32P) affects patients with invasive epithelial ovarian cancer after they had a second-look surgery that showed no signs of disease. Out of 69 patients, those who received 32P had an 86% chance of being disease-free five years later, compared to 67% for those who did not receive the treatment. This is important because it shows that 32P can improve survival rates without causing significant side effects. Who this helps: This helps patients with invasive epithelial ovarian cancer who are in clinical remission after surgery.

Plain English
This study looked at two 2-year-old boys, one with Becker muscular dystrophy and the other with Duchenne muscular dystrophy, to see if they showed signs of a severe reaction to certain anesthesia called malignant hyperthermia (MH). The tests showed that neither boy had this reaction, meaning they do not have the same risk for severe complications during surgery. This finding is important because it indicates that the muscle problems related to these conditions are different from the factors that trigger MH. Who this helps: This helps patients with Becker and Duchenne muscular dystrophy and their healthcare providers during surgical procedures.

Plain English
This study looked at specific genetic variations in a gene called Ha-ras to see if they were common in people with ovarian cancer compared to healthy individuals. Researchers examined DNA from 42 ovarian tumors and blood samples from 76 healthy people, finding a total of 18 genetic variations. The results showed that the rare variations in the Ha-ras gene were found at similar rates in both cancer patients and healthy individuals, meaning these genetic changes do not help to identify ovarian cancer. Who this helps: This research benefits doctors and researchers looking for effective ways to diagnose and understand ovarian cancer.

Plain English
This study looked at a rare condition where a person has two gallbladders instead of one. Researchers found that using ultrasound imaging can help identify this condition before surgery. Recognizing this abnormality early is important because it can prevent complications during gallbladder surgery. Who this helps: This benefits patients who might have gallbladder problems and doctors performing their surgeries.

Plain English
This study examined how well a memory test could tell the difference between people with true memory problems due to brain damage and those who were pretending to have memory issues. Researchers tested 18 brain-damaged individuals and 16 individuals without such damage, finding that the results backed up previous cut-off scores that help identify people who might be faking memory loss. This is important because it helps develop better ways to accurately assess memory complaints, which can impact diagnoses and treatments. Who this helps: This helps doctors better evaluate patients with memory complaints.

Plain English
This study looked at how effectively a treatment called intraperitoneal chromic phosphate (32P) can help women with ovarian cancer who had surgery and chemotherapy but were later assessed for any remaining disease. Among 118 patients, those who had no signs of cancer after surgery and received 32P had a survival rate of 89% over four years, compared to 67% for those who did not get the treatment. For patients with minimal remaining disease, the survival rates were 59% for those treated with 32P versus 22% for those without. This matters because it shows that 32P can improve survival rates for certain patients without causing significant side effects. Who this helps: This study helps ovarian cancer patients and their doctors by providing new options for treatment after surgery.

Plain English
This study looked at 73 patients with early-stage endometrial cancer who couldn't have surgery and were treated with radiation therapy instead. They found that 72% of patients with Stage I cancer were free of disease after 3 years, but only 36% of Stage II patients experienced the same outcome. The researchers highlighted that patients with lower-grade tumors had better survival rates, emphasizing the need to improve treatment for those with more aggressive cancers. Who this helps: This research helps patients with advanced endometrial cancer who cannot undergo surgery, as well as their doctors in planning effective treatment.

Plain English
This study focused on immune cells found in patients with advanced ovarian cancer, analyzing both the tumor and fluid in the abdomen (ascites) to see how well they respond to immune challenges. Researchers found that immune responses from these cells were significantly lower than those from normal blood; specifically, the immune reaction from tumor-infiltrating lymphocytes was less than 10% of normal blood. This matters because it highlights how ovarian cancer can weaken the immune system, potentially impacting the effectiveness of treatments. Who this helps: This information helps doctors and researchers understand the immune challenges faced by ovarian cancer patients, guiding better treatment strategies.

Plain English
This study looked at immune cells called macrophages found in ovarian cancer patients, specifically in fluid collected from the abdomen (ascites) and in solid tumors. The researchers found that these macrophages varied in size and activity, with some being able to suppress immune responses more than others. For instance, out of 10 tumor samples, 4 showed significant suppression of immune cells' activity, indicating the macrophages can sometimes weaken the body's defense against cancer. This research is important because understanding how these cells work can help develop better treatments for ovarian cancer. Who this helps: This information benefits patients with ovarian cancer and their doctors by guiding more effective treatment strategies.

Plain English
This study looked at the types of immune cells found in ovarian cancer tumors and fluids collected from patients. Researchers found that most of the fluid from the abdomen (ascites) contained immune cells, while tumor cells were less common, and patients with higher levels of certain immune cells tended to respond better to treatment. Specifically, T lymphocytes were more abundant in the ascites and tumor samples than in the blood, highlighting different immune responses in tumors compared to the rest of the body. Who this helps: This research helps doctors understand how immune cell presence in ovarian cancer can influence treatment outcomes for patients.

Plain English
This study focused on how fibrin, a protein involved in blood clotting, forms in two steps, using advanced imaging techniques to visualize its structure at different stages. Researchers found that early fibrin structures called protofibrils appear as expected, and that as these fibers come together, their diameter increases significantly. They also observed that higher salt concentrations slow down fibrin formation, which is important for understanding how blood clots can behave under different conditions. Who this helps: This research benefits patients with clotting disorders and doctors who treat them.

Plain English
This study looked at how well mezlocillin, a new type of penicillin, works to treat uncomplicated gonorrhea in 50 patients. Out of the 46 patients who were followed, 45 were successfully cured, resulting in a cure rate of 97.8%. Additionally, 10.8% of the men developed a follow-up condition known as post-gonococcal urethritis. Who this helps: This benefits patients with gonorrhea by providing a potential effective treatment option.

Plain English
This study looked at two rare cases of sigmoidovaginal fistulae, which are abnormal connections between the colon and vagina, caused by diverticular disease. Researchers discussed different ways to diagnose and treat these conditions, emphasizing that diverticular disease is the main cause of such fistulae. Understanding these issues is important because it helps improve patient care and treatment options. Who this helps: This benefits patients experiencing sigmoidovaginal fistulae and their doctors.

Plain English
This study looked at the effects of 11 weeks of endurance exercise training on heart structure and performance in 24 people. After the training, researchers found the left side of the heart had increased in size and mass, and the heart was pumping more effectively, with improvements in how well it contracted. These changes were important because they show that regular exercise can enhance heart health and function. Who this helps: This benefits patients looking to improve their cardiovascular health through exercise.

Plain English
This study looked at how effective cefuroxime, a new antibiotic, is in treating gonorrhea in 1,196 patients (856 men and 340 women). The results showed that 94.8% to 99.3% of patients were cured, and the drug had no significant side effects. This matters because cefuroxime is a strong alternative to penicillin for treating gonorrhea, especially against strains that are resistant to other antibiotics. Who this helps: This helps patients with gonorrhea and doctors treating them.

Plain English
This research focuses on a new small and sturdy light source that emits far ultraviolet light, specifically in the range of 1150 to 3200 angstroms. The findings show that this light source is very bright and effective for both laboratory and space use, passing tough tests for spacecraft conditions. This advancement is important because it can improve the precision of scientific instruments that measure light sensitivity. Who this helps: Scientists and researchers using spectrometric instruments in both labs and space missions.

Plain English
This study looked at the erythrocyte sedimentation rate (ESR) in 722 people with syphilis, finding that it was higher in nearly all cases: 66% of those with early syphilis without antibodies, 80% with antibodies, and 100% of those with secondary syphilis. While the ESR isn't very useful for managing syphilis overall, it can be helpful for monitoring late-stage syphilis after treatment. Who this helps: This helps healthcare providers monitor patients who have had late syphilis.

Plain English
This study looked at different ways to treat non-specific urethritis using tetracycline. Researchers tested two doses of tetracycline over different time periods and found that both higher doses over shorter times and lower doses over longer times worked equally well, but not better than the standard treatment of lower doses for just four days. This is important because it shows that the usual treatment is still effective, helping avoid unnecessary longer courses of antibiotics. Who this helps: Patients suffering from non-specific urethritis.

Plain English
This study looked at 88 cases of early-stage cervical cancer treated with radiation at a hospital in North Carolina. Researchers found that the total radiation dose and specific radiation measurements were linked to better control of the disease. Specifically, the overall radiation calculation showed a strong connection to how well the cancer was managed, indicating that understanding these doses can improve treatment outcomes. Who this helps: Patients with cervical cancer receiving radiation therapy.